Freedom of Information request on the clinical study report for Amitriptyline 25 mg Film-coated Tablets (PL 13606/0251) (FOI 21/746).
Published 29 December 2021
© Crown copyright 2021
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-19-july-2021/freedom-of-information-request-on-the-clinical-study-report-for-amitriptyline-25-mg-film-coated-tablets-pl-136060251-foi-21746
20th July 2021
FOI 21/746
Dear
Thank you for your communication, dated 29 June 2021, in which you requested the clinical study report for Amitriptyline 25 mg Film-coated Tablets (PL 13606/0251).
Please note that a bioequivalence study was not required for the approval of the marketing authorisation application for Amitriptyline 25 mg Film-coated Tablets (PL 13606/0251). A biowaiver was accepted according to the criteria for BCS-based biowaivers, as outlined in the CHMP Guideline on the investigation of bioequivalence (CPMP/EWP/QWP/1401/98 Rev. 1/ Corr **).
For further information, please see the link below to the Public Assessment Report for Amitriptyline 10 mg, 25 mg and 50 mg Film-coated Tablets (PL 13606/0250-0252).
https://mhraproducts4853.blob.core.windows.net/docs/5f89e66128de5d40db7502215109cb2c234a0288
I now consider this request closed. If you require any further information, please respond to the FOI Licensing Team at FOILicensing@mhra.gov.uk.
If you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date you receive this response and addressed to: info@mhra.gov.uk.
Please remember to quote the reference number above in any future communications.
If you were to remain dissatisfied with the outcome of the internal review, you would have the right to apply directly to the Information Commissioner for a decision. Please bear in mind that the Information Commissioner will not normally review our handling of your request unless you have first contacted us to conduct an internal review. The Information Commissioner can be contacted at:
Information Commissioner’s Office
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF
Yours sincerely,
The FOI Licensing Team